Product infomation

CynosBio Selected for AMED Support to Advance Japan-Approved SAKRACY® Toward an International Phase 3 Trial

Newsletters

U.S.-Ready Leadership and Governance Structure to Support Global Expansion

Newsletters

Announcement of New Management Structure

Newsletters

Company Name Change and Headquarters Relocation

Company information

Strategic Agreement with FBRI for R&D and Manufacturing Advancement

Company information

Completion of Series C Financing of JPY 2.38 Billion

Company information

Announcement on change of representative director

Company information

Announcement on year-end and new year holidays

Company information

Announcement on year-end and new year holidays

Company information

About response to the COVID-19 state of emergency lifted